Caricamento...
Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
Antipsychotics have been utilized as the standard treatment for schizophrenia regardless of illness phase where antipsychotic monotherapy (APM) is routinely recommended as the gold standard rather than antipsychotic polypharmacy (APP). However, approximately 20 to 40% of patients with schizophrenia...
Salvato in:
| Pubblicato in: | Chonnam Med J |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Chonnam National University Medical School
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520369/ https://ncbi.nlm.nih.gov/pubmed/33014754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2020.56.3.157 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|